Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2014 Net Income-$400.85K-$400.85KderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$384,304N/M Operating Cash Flowderived-$282,464— Free Cash Flowderived-$282,464N/M ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end